London Stock Exchange welcomes BiVictriX Therapeutics plc

London Stock Exchange today welcomes BiVictriX Therapeutics plc (“BiVictriX”), a rapidly emerging drug discovery and development company that begins trading on AIM under the ticker symbol BVX, following a successful initial public offering.

BiVictriX has successfully raised gross proceeds of £7.5 million by way of a placing and subscription at a market capitalisation of approximately £13.2 million. The funds will enable BiVictriX to accelerate its growth strategy and expedite the development and delivery of its next-generation, highly selective cancer therapeutics.

Founded by Tiffany Thorn in 2017, BiVictriX is applying a novel approach, derived from frontline clinical experience from within the NHS, to create safer, more effective cancer therapeutics. BiVictriX has developed a proprietary platform and the resulting Bi-Cygni® therapeutics are uniquely selective for the specific cancers, potentially enabling higher dosing and more aggressive tumour eradication, while reducing life-threatening treatment-related side effects.

Tiffany Thorn, Founder and CEO of BiVictriX, said: “Today’s listing on London’s AIM is a major milestone for BiVictriX. Our vision is to revolutionise cancer therapy for the most difficult to treat cancers, making curative treatments available to all. The funds raised will help us to accelerate our growth strategy and expedite the development and delivery of our pioneering, highly selective cancer therapeutics to patients diagnosed with some of the most challenging cancers. Supporting patients who are currently in urgent need of more effective medicines.

“I would like to take this opportunity to offer our sincere gratitude and thanks to all of our staff, advisers and shareholders who have been instrumental in getting us to where we are today. I would also like to take this opportunity to welcome new shareholders to the register and thank them for their support in enabling us to continue to carry out this critical work. I look forward to life as a public company and progressing our development programmes to the next stage with the support of our shareholders.”

Advisers to the IPO include:

  • SP Angel Corporate Finance LLP – Nominated Adviser and Broker
  • Acceleris Capital Limited – Financial Adviser
  • Slater Heelis Limited – Solicitors to BiVictriX
  • Gowlings WLG (UK) LLP – Solicitors to SP Angel
  • Crowe U.K. LLP – Reporting Accountant and Auditor
  • Consilium Strategic Communications – Financial Public Relations Adviser

Quick facts

Track
Market: AIM
Instrument market cap (£m)
18.84
Listing/Admission to trading
11 Aug 2021
Looking for new and recent issues?

More recent

92.5
London Stock Exchange welcomes Graft Polymer Plc to the Main Market

The London Stock Exchange today welcomes Graft Polymer (UK) PLC, a business focused on the development of polymer modification, bio/food supplements and drug delivery systems, to the Main Market, trading under the ticker symbol “GPL”.

Graft Polymer is an early-stage company with a state-of-the-art polymer research and development, manufa

Learn more
97.567
London Stock Exchange welcomes Genflow Biosciences Plc to the Main Market

London Stock Exchange today welcomes Genflow Biosciences Plc, a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with advanced age, to the Standard Listing Segment of the Main Market, under the ticker symbol "GENF".

Genflow Biosciences opened th

Learn more
74.96
London Stock Exchange welcomes East Star Resources Plc and their readmission to the Main Market

London Stock Exchange welcomes the readmission of East Star Resources, a company focused on the discovery and development of gold, copper, and base metals in Kazakhstan, to the Main Market under the ticker “EST”. The company raised gross proceeds of £3.1 million via a placing and subscription of 62,000,000 shares at £0.05 per share, delivering a ma

Learn more
168
London Stock Exchange celebrates FTSE Russell’s index partnership with Abu Dhabi Securities Exchange

Today, London Stock Exchange markets were opened by Abu Dhabi Securities Exchange and FTSE Russell to mark their partnership and the launch of the FTSE ADX Index Series.

FTSE ADX General Index FTSE ADX Sector Indexes FTSE Russell provides daily index calculations on the ADX General Index FTSE ADX General Index replaces the ADX General Index FTSE Russ

Learn more